These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 20663884)

  • 1. Analysis of CD44-hyaluronan interactions in an artificial membrane system: insights into the distinct binding properties of high and low molecular weight hyaluronan.
    Wolny PM; Banerji S; Gounou C; Brisson AR; Day AJ; Jackson DG; Richter RP
    J Biol Chem; 2010 Sep; 285(39):30170-80. PubMed ID: 20663884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering.
    Yang C; Cao M; Liu H; He Y; Xu J; Du Y; Liu Y; Wang W; Cui L; Hu J; Gao F
    J Biol Chem; 2012 Dec; 287(51):43094-107. PubMed ID: 23118219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular weight impact on the mechanical forces between hyaluronan and its receptor.
    Jiang L; Liu G; Liu H; Han J; Liu Z; Ma H
    Carbohydr Polym; 2018 Oct; 197():326-336. PubMed ID: 30007620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular weight specific impact of soluble and immobilized hyaluronan on CD44 expressing melanoma cells in 3D collagen matrices.
    Sapudom J; Ullm F; Martin S; Kalbitzer L; Naab J; Möller S; Schnabelrauch M; Anderegg U; Schmidt S; Pompe T
    Acta Biomater; 2017 Mar; 50():259-270. PubMed ID: 27965172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid binding to CD44S is indiscriminate of molecular weight.
    Kim SJ; Owen SC
    Biochim Biophys Acta Biomembr; 2020 Sep; 1862(9):183348. PubMed ID: 32428448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is special about 200 kDa hyaluronan that activates hyaluronan receptor signaling?
    Weigel PH; Baggenstoss BA
    Glycobiology; 2017 Sep; 27(9):868-877. PubMed ID: 28486620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical modification of hyaluronan oligosaccharides differentially modulates hyaluronan-hyaladherin interactions.
    Dodd RJ; Blundell CD; Sattelle BM; Enghild JJ; Milner CM; Day AJ
    J Biol Chem; 2024 Sep; 300(9):107668. PubMed ID: 39128716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structures of the Cd44-hyaluronan complex provide insight into a fundamental carbohydrate-protein interaction.
    Banerji S; Wright AJ; Noble M; Mahoney DJ; Campbell ID; Day AJ; Jackson DG
    Nat Struct Mol Biol; 2007 Mar; 14(3):234-9. PubMed ID: 17293874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inter-α-inhibitor impairs TSG-6-induced hyaluronan cross-linking.
    Baranova NS; Foulcer SJ; Briggs DC; Tilakaratna V; Enghild JJ; Milner CM; Day AJ; Richter RP
    J Biol Chem; 2013 Oct; 288(41):29642-53. PubMed ID: 24005673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response.
    Mizrahy S; Raz SR; Hasgaard M; Liu H; Soffer-Tsur N; Cohen K; Dvash R; Landsman-Milo D; Bremer MG; Moghimi SM; Peer D
    J Control Release; 2011 Dec; 156(2):231-8. PubMed ID: 21745506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-induced structural changes of the CD44 hyaluronan-binding domain revealed by NMR.
    Takeda M; Ogino S; Umemoto R; Sakakura M; Kajiwara M; Sugahara KN; Hayasaka H; Miyasaka M; Terasawa H; Shimada I
    J Biol Chem; 2006 Dec; 281(52):40089-95. PubMed ID: 17085435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 and hyaluronan binding by human myeloid cells.
    Smadja-Joffe F; Legras S; Girard N; Li Y; Delpech B; Bloget F; Morimoto K; Le Bousse-Kerdiles C; Clay D; Jasmin C; Levesque JP
    Leuk Lymphoma; 1996 May; 21(5-6):407-20, color plates following 528. PubMed ID: 9172805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atomistic fingerprint of hyaluronan-CD44 binding.
    Vuorio J; Vattulainen I; Martinez-Seara H
    PLoS Comput Biol; 2017 Jul; 13(7):e1005663. PubMed ID: 28715483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of CD44-mediated cancer cell uptake and intracellular distribution of hyaluronan-grafted liposomes.
    Qhattal HS; Liu X
    Mol Pharm; 2011 Aug; 8(4):1233-46. PubMed ID: 21696190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermediate Molecular Mass Hyaluronan and CD44 Receptor Interactions Enhance Neutrophil Phagocytosis and IL-8 Production via p38- and ERK1/2-MAPK Signalling Pathways.
    Lu CH; Lin CH; Li KJ; Shen CY; Wu CH; Kuo YM; Lin TS; Yu CL; Hsieh SC
    Inflammation; 2017 Oct; 40(5):1782-1793. PubMed ID: 28730511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms regulating the binding activity of CD44 to hyaluronic acid.
    Liu D; Liu T; Li R; Sy MS
    Front Biosci; 1998 Jul; 3():d631-6. PubMed ID: 9634638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronan size alters chondrogenesis of adipose-derived stem cells via the CD44/ERK/SOX-9 pathway.
    Wu SC; Chen CH; Wang JY; Lin YS; Chang JK; Ho ML
    Acta Biomater; 2018 Jan; 66():224-237. PubMed ID: 29128538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential activation of ERK and Rac mediates the proliferative and anti-proliferative effects of hyaluronan and CD44.
    Kothapalli D; Flowers J; Xu T; Puré E; Assoian RK
    J Biol Chem; 2008 Nov; 283(46):31823-9. PubMed ID: 18806267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronan binding by cell surface CD44.
    Lesley J; Hascall VC; Tammi M; Hyman R
    J Biol Chem; 2000 Sep; 275(35):26967-75. PubMed ID: 10871609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor.
    Platt VM; Szoka FC
    Mol Pharm; 2008; 5(4):474-86. PubMed ID: 18547053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.